Litcius/Paper detail

Baricitinib in Alopecia Areata

Andrew G. Messenger, Matthew Harries

2022New England Journal of Medicine16 citationsDOI

Abstract

For many people, alopecia areata is a transient problem, in which small patches of hair loss recover spontaneously within a few months. But for others, the reality is rather different. An Italian study showed that one third of patients with scalp hair loss of 25 to 50% still had active patchy disease at long-term follow-up, with a further third having progression to alopecia totalis or alopecia universalis, terms that vividly capture the extreme extent of disease and from which recovery is rare.1 For many patients with severe disease, medical treatments do not work, and they face difficulty in coping with . . .

Topics & Concepts

Alopecia areataScalpHair lossAlopecia universalisDermatologyMedicineDiseasePathologyHair Growth and DisordersCutaneous lymphoproliferative disorders researchAutoimmune and Inflammatory Disorders
Baricitinib in Alopecia Areata | Litcius